Mechanisms of cefadroxil uptake in the choroid plexus: Studies in wild-type and PEPT2 knockout mice

被引:34
|
作者
Ocheltree, SM
Shen, H
Hu, YJ
Xiang, JM
Keep, RF
Smith, DE
机构
[1] Univ Michigan, Upjohn Ctr 4302A, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Physiol, Ann Arbor, MI 48109 USA
关键词
D O I
10.1124/jpet.103.060400
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The choroid plexus uptake of [H-3] cefadroxil was studied in peptide transporter 2 (PEPT2) wild-type and null mice as a function of temperature, transport inhibitors, pH, and saturability. At normal pH (7.4) and temperature (37degreesC), the uptake of 1 muM cefadroxil was reduced by 83% in PEPT2(-/-) mice as compared with PEPT2(+/+) mice (p<0.001). A further reduction was achieved in null animals by reducing the temperature to 4 degrees C, or by adding saturating concentrations of unlabeled cefadroxil or p-aminohippurate (p<0.05). Glycylsarcosine coadministration could inhibit the uptake of cefadroxil in PEPT2(+/+) mice (p<0.01) but not PEPT2(-/-) mice. Although a proton-stimulated uptake of cefadroxil was demonstrated in PEPT2(+/+) mice (pH 6.5 versus pH 7.4; p<0.01), no pH dependence was observed in PEPT2(-/-) mice. Kinetic parameters for cefadroxil (without p-aminohippurate) in wild-type mice were: V-max=5.4 pmol/mg/min, K-m=34 muM, and K-d=0.0069 mul/mg/min; in the presence of p-aminohippurate, the parameters were: V-max=4.1 pmol/mg/min, K-m=27 muM, and K-d=0.0064 mul/mg/min. In null animals, the kinetic parameters of cefadroxil (without p-aminohippurate) were: V-max=2.7 pmol/mg/min, K-m=110 muM, and K-d=0.0084 mul/mg/min; in the presence of p-aminohippurate, only a K-d=0.010 mul/mg/min was observed. Based on kinetic and inhibitor analyses, it was determined that (under linear conditions), 80 to 85% of cefadroxil's uptake in choroid plexus is mediated by PEPT2, 10 to 15% by organic anion transporter(s), and 5% by nonspecific mechanisms. These findings demonstrate that PEPT2 is the primary transporter responsible for cefadroxil uptake in the choroid plexus. Moreover, the data suggest a role for PEPT2 in the clearance of peptidomimetics from cerebrospinal fluid.
引用
收藏
页码:462 / 467
页数:6
相关论文
共 50 条
  • [1] Role and relevance of peptide transporter 2 (PEPT2) in the kidney and choroid plexus: In vivo studies with glycylsarcosine in wild-type and PEPT2 knockout mice
    Ocheltree, SM
    Shen, H
    Hu, YJ
    Keep, RF
    Smith, DE
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (01): : 240 - 247
  • [2] Impact of PEPT2 on the disposition of glycylsarcosine and cefadroxil in cerebrospinal fluid, choroid plexus, and brain parenchyma following intracerebroventricular administration to wild-type and Pept2 null mice
    Smith, David E.
    Hu, Yongjun
    Shen, Hong
    Nagaraja, Tavarekere N.
    Fenstermacher, Joseph D.
    Keep, Richard F.
    DRUG METABOLISM REVIEWS, 2010, 42 : 292 - 293
  • [3] Population pharmacokinetic modeling of cefadroxil renal transport in wild-type and Pept2 knockout mice
    Xie, Yehua
    Shen, Hong
    Hu, Yongjun
    Feng, Meihua Rose
    Smith, David E.
    XENOBIOTICA, 2016, 46 (04) : 342 - 349
  • [4] Role of PEPT2 in the Choroid Plexus Uptake of Glycylsarcosine and 5-Aminolevulinic Acid: Studies in Wild-Type and Null Mice
    Scott M. Ocheltree
    Hong Shen
    Yongjun Hu
    Jianming Xiang
    Richard F. Keep
    David E. Smith
    Pharmaceutical Research, 2004, 21 : 1680 - 1685
  • [5] Role of PEPT2 in the choroid plexus uptake of glycylsarcosine and 5-aminolevulinic acid: Studies in wild-type and null mice
    Ocheltree, SM
    Shen, H
    Hu, YJ
    Xiang, JM
    Keep, RF
    Smith, DE
    PHARMACEUTICAL RESEARCH, 2004, 21 (09) : 1680 - 1685
  • [6] Influence of genetic knockout of Pept2 on the in vivo disposition of endogenous and exogenous carnosine in wild-type and Pept2 null mice
    Kamal, Mohamed A.
    Jiang, Huidi
    Hu, Yongjun
    Keep, Richard. F.
    Smith, David E.
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2009, 296 (04) : R986 - R991
  • [7] Distribution of glycylsarcosine and cefadroxil among cerebrospinal fluid, choroid plexus, and brain parenchyma after intracerebroventricular injection is markedly different between wild-type and Pept2 null mice
    Smith, David E.
    Hu, Yongjun
    Shen, Hong
    Nagaraja, Tavarekere N.
    Fenstermacher, Joseph D.
    Keep, Richard F.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2011, 31 (01): : 250 - 261
  • [8] Carnosine uptake in rat choroid plexus primary cell cultures and choroid plexus whole tissue from PEPT2 null mice
    Teuscher, NS
    Shen, H
    Shu, C
    Xiang, JM
    Keep, RF
    Smith, DE
    JOURNAL OF NEUROCHEMISTRY, 2004, 89 (02) : 375 - 382
  • [9] Functional evidence for presence of PEPT2 in rat choroid plexus: studies with glycylsarcosine
    Teuscher, NS
    Novotny, A
    Keep, RF
    Smith, DE
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 294 (02): : 494 - 499
  • [10] Targeted disruption of the PEPT2 gene markedly reduces dipeptide uptake in choroid plexus
    Shen, H
    Smith, DE
    Keep, RF
    Xiang, JM
    Brosius, FC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (07) : 4786 - 4791